(Q40830056)

24 September 2017

1 reference

title

Neurofibromatosis 1 in childhood (English)

1 reference

24 September 2017

1

1 reference

24 September 2017

publication date

1 December 1998

1 reference

Seminars in pediatric neurology

24 September 2017

published in

1 reference

24 September 2017

volume

5

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

231-242

1 reference

Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

NF1: a prevalent cause of tumorigenesis in human cancers?

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Type 1 neurofibromatosis and the pediatric patient

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Relationship between café-au-lait spots as the only symptom and peripheral neurofibromatosis (NF1): a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Lisch nodules in neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Recent developments in the diagnosis and management of neurofibromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neuropsychological profile of children with neurofibromatosis, brain tumor, or both.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Intellectual impairment in neurofibromatosis 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

COGNITIVE FUNCTION AND ACADEMIC PERFORMANCE IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Precocious puberty in children with neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Evolution of white matter lesions in neurofibromatosis type 1: MR findings

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

MRI findings in children with neurofibromatosis type 1: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neurofibromatosis type 1: the cognitive phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neurofibromatosis Type 1 Due to Germ-Line Mosaicism in a Clinically Normal Father

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

The neurofibromatosis type 1 gene encodes a protein related to GAP

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Distribution of 13 truncating mutations in the neurofibromatosis 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Autosomal dominant multiple café-au-lait spots and neurofibromatosis-1: evidence of non-linkage

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Exclusion of the neurofibromatosis 1 locus in a family with inherited café-au-lait spots

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Familial café au lait spots: a variant of neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980002-8

7 January 2021

10.1016/S1071-9091(98)80002-8

Identifiers

DOI

1 reference

24 September 2017

1 reference